A Phase III Open-Label, Multi-Centre, Randomised Study Comparing NUC-1031 plus Cisplatin to Gemcitabine plus Cisplatin in Patients with Previously Untreated Locally Advanced or Metastatic Biliary Tract Cancer.

  • Zalcberg, John (Primary Chief Investigator (PCI))
  • Hawkins, Cheryl-Ann, (Project Manager)

Project: Research

StatusActive
Effective start/end date8/10/19 → 31/12/24
View all
View less

Keywords

  • Medical Oncology
  • Biliary Tract Cancer
  • Clinical trial